Linking chronic kidney disease and Parkinson's disease: a literature review
- PMID: 32990929
- DOI: 10.1007/s11011-020-00623-1
Linking chronic kidney disease and Parkinson's disease: a literature review
Abstract
Chronic kidney disease (CKD) has been typically implicated in cardiovascular risk, considering the function the kidney has related to blood pressure, vitamin D, red blood cell metabolism, and electrolyte and acid-base regulation. However, neurological consequences are also attributed to this disease. Among these, recent large epidemiological studies have demonstrated an increased risk for Parkinson's disease (PD) in patients with CKD. Multiple studies have evaluated individually the association of blood pressure, vitamin D, and red blood cell dysmetabolism with PD, however, no study has reviewed the potential mechanisms related to these components in context of CKD and PD. In this review, we explored the association of CKD and PD and linked the components of the former to propose potential pathways explaining a future increased risk for PD, where renin-angiotensin system, oxidative stress, and inflammation have a main role. Potential preventive and therapeutic interventions based on these associations are also explored. More preclinical studies are needed to confirm the potential link of CKD conditions and future PD risk, whereas more interventional studies targeting this association are warranted to confirm their potential benefit in PD.
Keywords: Anemia; Chronic kidney disease; Oxidative stress; Parkinson’s disease; Renin-angiotensin system.
References
-
- Agarwal R, Nissenson AR, Batlle D, Coyne DW, Trout JR, Warnock DG (2003) Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med 115:291–297 - PubMed
-
- Annuk M, Fellström B, Akerblom O et al (2001) Oxidative stress markers in pre-uremic patients. Clin Nephrol 56(4):308–314 - PubMed
-
- Asahina M, Vichayanrat E, Low DA et al (2013) Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurol Neurosurg Psychiatry 84(6):674–680 - PubMed
-
- Ashby DR, Gale DP, Busbridge M, Murphy KG, Duncan ND, Cairns TD, Taube DH, Bloom SR, Tam FWK, Chapman RS, Maxwell PH, Choi P (2009) Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int 75(9):976–981 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
